US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cue Biopharma, Inc.

0.2848

-0.0084-2.86%

Post-market: 0.2720-0.0128-4.49%16:25 EST

Volume:454.93K

Turnover:129.90K

Market Cap:25.98M

PE:-0.65

High:0.3029

Open:0.2930

Low:0.2795

Close:0.2932

52wk High:1.40

52wk Low:0.2302

Shares:91.24M

Float Shares:90.97M

Volume Ratio:1.39

T/O Rate:0.50%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4366

EPS(LYR):-0.7221

ROE:-195.19%

ROA:-62.31%

PB:1.96

PE(LYR):-0.39

Loading ...

Overview Company News Filings

Cue Biopharma Reports Positive Preclinical Safety Data for CUE-401

Cue Biopharma Inc - Cue-401 Well Tolerated With No Adverse Events in Studies

THOMSON REUTERS

Press Release: Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer

Cue Biopharma’s CUE-101 Trial Hits Completion: What It Means for Cancer Investors

Director Pasha Sarraf Reports Acquisition of Cue Biopharma Inc. Common Shares

BRIEF-Cue Biopharma Announces Pricing Of $10 Million Public Offering

Cue Biopharma Inc - Shares and Warrants Sold at Combined Price of $0.28

THOMSON REUTERS

Press Release: Cue Biopharma Announces Proposed Public Offering

Cue Biopharma Chief Medical Officer Matteo Levisetti to Depart

Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors

BRIEF-Immunoscape Signs Deal With Cue Biopharma To Develop Solid Tumor Cancer Treatment

Immunoscape: Entered in-Licensing Deal With Cue Biopharma for Development of New Class of Therapies to Attack Solid Tumor Cancers

THOMSON REUTERS

Cue Biopharma Licenses Immuno-STAT® Oncology Technology to ImmunoScape

Cue Biopharma Q3 collaboration revenue falls

Cue Biopharma Q3 EPS $(0.07) Beats $(0.09) Estimate, Sales $2.149M Miss $2.290M Estimate

Cue Biopharma Names Usman Azam President and CEO

Cue Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights

THOMSON REUTERS

BRIEF-Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors

Cue Biopharma Inc. Files Initial Statement of Beneficial Ownership for CEO and Director Usman Azam

BRIEF-Cue Biopharma Appoints New CEO, Shifts Focus to Autoimmune Therapies

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CUE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CUE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUE\",,,,,undefined,":{"symbol":"CUE","market":"US","secType":"STK","nameCN":"Cue Biopharma, Inc.","latestPrice":0.2848,"timestamp":1771621200000,"preClose":0.2932,"halted":0,"volume":454927,"hourTrading":{"tag":"盘后","latestPrice":0.272,"preClose":0.2848,"latestTime":"16:25 EST","volume":546,"amount":148.5308,"timestamp":1771622750089,"change":-0.0128,"changeRate":-0.044944,"amplitude":0.044944},"delay":0,"changeRate":-0.028649386084583964,"floatShares":90972099,"shares":91237736,"eps":-0.43659,"marketStatus":"Market Closed","change":-0.0084,"latestTime":"02-20 16:00:00 EST","open":0.293,"high":0.302899,"low":0.2795,"amount":129896.089616,"amplitude":0.079806,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.43659,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1514869200000,"exchange":"NASDAQ","adjPreClose":0.2932,"preHourTrading":{"tag":"盘前","latestPrice":0.2932,"preClose":0.2932,"latestTime":"08:57 EST","volume":40504,"amount":11857.17660352,"timestamp":1771595834301,"change":0,"changeRate":0,"amplitude":0.010914},"postHourTrading":{"tag":"盘后","latestPrice":0.272,"preClose":0.2848,"latestTime":"16:25 EST","volume":546,"amount":148.5308,"timestamp":1771622750089,"change":-0.0128,"changeRate":-0.044944,"amplitude":0.044944},"volumeRatio":1.3881973908112226,"impliedVol":0.7367,"impliedVolPercentile":0.7012},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUE\",,,,,undefined,":{"symbol":"CUE","floatShares":90972099,"roa":"-62.31%","roe":"-195.19%","lyrEps":-0.722087,"volumeRatio":1.3881973908112226,"shares":91237736,"dividePrice":0,"high":0.302899,"amplitude":0.079806,"preClose":0.2932,"low":0.2795,"week52Low":0.2302,"pbRate":"1.96","psRate":"3.66","week52High":1.4,"institutionHeld":0,"latestPrice":0.2848,"eps":-0.43659,"divideRate":0,"volume":454927,"delay":0,"ttmEps":-0.43659,"open":0.293,"prevYearClose":0.3054,"prevWeekClose":0.3066,"prevMonthClose":0.3348,"prevQuarterClose":0.3054,"fiveDayClose":0.3,"twentyDayClose":0.3648,"sixtyDayClose":0.595},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"CUE","fiscalQuarterEnding":"2025/09","expectedEps":-0.1,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2025-08-12","symbol":"CUE","fiscalQuarterEnding":"2025/06","expectedEps":-0.13,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.09},{"market":"US","date":"2025-05-12","symbol":"CUE","fiscalQuarterEnding":"2025/03","expectedEps":-0.14,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.17},{"market":"US","date":"2025-03-31","symbol":"CUE","fiscalQuarterEnding":"2024/12","expectedEps":-0.16,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2024-11-14","symbol":"CUE","fiscalQuarterEnding":"2024/09","expectedEps":-0.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.17}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CUE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1756098000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CUE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CUE","date":"2026-02-19","current":-0.652328,"percent":0.967506,"low":-12.093299,"twenty":-4.666591,"median":-2.20954,"eighty":-1.442504,"high":-0.470408,"avg":-3.345121,"sd":2.763002,"marketCap":27106731},"quantilePoints":[{"date":"2021-02-26","current":-9.673677,"twenty":-13.291633,"median":-8.827524,"eighty":-4.016062,"marketCap":412088561},{"date":"2021-03-05","current":-9.275642,"twenty":-13.243912,"median":-8.85065,"eighty":-4.018032,"marketCap":395132676},{"date":"2021-03-12","current":-10.711232,"twenty":-13.161893,"median":-8.856284,"eighty":-4.024035,"marketCap":479701687},{"date":"2021-03-19","current":-9.813529,"twenty":-13.057154,"median":-8.875927,"eighty":-4.036643,"marketCap":439498117},{"date":"2021-03-26","current":-7.936513,"twenty":-13.00278,"median":-8.863188,"eighty":-4.0424,"marketCap":355436107},{"date":"2021-04-01","current":-8.364962,"twenty":-12.957282,"median":-8.854434,"eighty":-4.044346,"marketCap":374624175},{"date":"2021-04-09","current":-8.351361,"twenty":-12.872588,"median":-8.849249,"eighty":-4.049607,"marketCap":374015030},{"date":"2021-04-16","current":-8.732205,"twenty":-12.775656,"median":-8.802611,"eighty":-4.059533,"marketCap":391071090},{"date":"2021-04-23","current":-8.296954,"twenty":-12.637665,"median":-8.793412,"eighty":-4.069237,"marketCap":371578450},{"date":"2021-04-30","current":-8.261326,"twenty":-12.512747,"median":-8.784641,"eighty":-4.072024,"marketCap":369982818},{"date":"2021-05-07","current":-7.668799,"twenty":-12.42627,"median":-8.739005,"eighty":-4.082927,"marketCap":343446540},{"date":"2021-05-14","current":-9.655835,"twenty":-12.366404,"median":-8.784641,"eighty":-4.094364,"marketCap":429413536},{"date":"2021-05-21","current":-9.888931,"twenty":-12.302925,"median":-8.793412,"eighty":-4.097886,"marketCap":439779774},{"date":"2021-05-28","current":-10.129091,"twenty":-12.265463,"median":-8.802611,"eighty":-4.101802,"marketCap":450460139},{"date":"2021-06-04","current":-9.380358,"twenty":-12.239931,"median":-8.828131,"eighty":-4.103803,"marketCap":417162528},{"date":"2021-06-11","current":-9.408612,"twenty":-12.217391,"median":-8.852584,"eighty":-4.106853,"marketCap":418419042},{"date":"2021-06-18","current":-8.878848,"twenty":-12.169565,"median":-8.863188,"eighty":-4.111707,"marketCap":394859411},{"date":"2021-06-25","current":-9.507501,"twenty":-12.152308,"median":-8.870091,"eighty":-4.112043,"marketCap":422816839},{"date":"2021-07-02","current":-8.433846,"twenty":-12.143111,"median":-8.856284,"eighty":-4.113389,"marketCap":375069321},{"date":"2021-07-09","current":-8.010034,"twenty":-12.130185,"median":-8.851617,"eighty":-4.113389,"marketCap":356221616},{"date":"2021-07-16","current":-7.162412,"twenty":-12.130185,"median":-8.807013,"eighty":-4.115909,"marketCap":318526207},{"date":"2021-07-23","current":-7.409635,"twenty":-12.108841,"median":-8.796824,"eighty":-4.118411,"marketCap":329520702},{"date":"2021-07-30","current":-7.36019,"twenty":-12.101604,"median":-8.785206,"eighty":-4.118411,"marketCap":327321803},{"date":"2021-08-06","current":-7.572096,"twenty":-12.064323,"median":-8.774953,"eighty":-4.122558,"marketCap":336745655},{"date":"2021-08-13","current":-7.970725,"twenty":-12.052206,"median":-8.739005,"eighty":-4.123434,"marketCap":350057668},{"date":"2021-08-20","current":-7.547437,"twenty":-12.04941,"median":-8.730275,"eighty":-4.125097,"marketCap":331467747},{"date":"2021-08-27","current":-8.88187,"twenty":-12.032979,"median":-8.714128,"eighty":-4.127664,"marketCap":390073261},{"date":"2021-09-03","current":-8.472931,"twenty":-12.021075,"median":-8.711363,"eighty":-4.134826,"marketCap":372113507},{"date":"2021-09-10","current":-8.530326,"twenty":-12.018253,"median":-8.700544,"eighty":-4.142609,"marketCap":374634174},{"date":"2021-09-17","current":-9.262112,"twenty":-12.007247,"median":-8.70702,"eighty":-4.144555,"marketCap":406772682},{"date":"2021-09-24","current":-10.402836,"twenty":-11.980812,"median":-8.712746,"eighty":-4.147748,"marketCap":456870944},{"date":"2021-10-01","current":-10.481754,"twenty":-11.974668,"median":-8.732205,"eighty":-4.152564,"marketCap":460336862},{"date":"2021-10-08","current":-9.434296,"twenty":-11.974305,"median":-8.746192,"eighty":-4.153568,"marketCap":414334684},{"date":"2021-10-15","current":-9.039706,"twenty":-11.960363,"median":-8.784075,"eighty":-4.161604,"marketCap":397005096},{"date":"2021-10-22","current":-8.544675,"twenty":-11.941431,"median":-8.782752,"eighty":-4.163613,"marketCap":375264341},{"date":"2021-10-29","current":-8.759906,"twenty":-11.932236,"median":-8.784075,"eighty":-4.171716,"marketCap":384716843},{"date":"2021-11-05","current":-10.001072,"twenty":-11.888513,"median":-8.789309,"eighty":-4.180669,"marketCap":439226273},{"date":"2021-11-12","current":-11.219329,"twenty":-11.844059,"median":-8.799421,"eighty":-4.183257,"marketCap":525961265},{"date":"2021-11-19","current":-10.047262,"twenty":-11.844059,"median":-8.806406,"eighty":-4.206821,"marketCap":471014829},{"date":"2021-11-26","current":-8.685495,"twenty":-11.834144,"median":-8.812157,"eighty":-4.214452,"marketCap":407175327},{"date":"2021-12-03","current":-7.703126,"twenty":-11.813833,"median":-8.802952,"eighty":-4.223496,"marketCap":361121956},{"date":"2021-12-10","current":-7.852175,"twenty":-11.793438,"median":-8.79382,"eighty":-4.231848,"marketCap":368109364},{"date":"2021-12-17","current":-8.001224,"twenty":-11.76607,"median":-8.785206,"eighty":-4.238678,"marketCap":375096772},{"date":"2021-12-23","current":-8.428047,"twenty":-11.746809,"median":-8.781429,"eighty":-4.242696,"marketCap":395106168},{"date":"2021-12-31","current":-7.662477,"twenty":-11.735687,"median":-8.762868,"eighty":-4.249999,"marketCap":359216299},{"date":"2022-01-07","current":-7.140805,"twenty":-11.726456,"median":-8.739005,"eighty":-4.259681,"marketCap":334760370},{"date":"2022-01-14","current":-6.741082,"twenty":-11.710378,"median":-8.730275,"eighty":-4.260643,"marketCap":316021412},{"date":"2022-01-21","current":-6.097462,"twenty":-11.68744,"median":-8.712746,"eighty":-4.263834,"marketCap":285848514},{"date":"2022-01-28","current":-4.898294,"twenty":-11.671132,"median":-8.70702,"eighty":-4.2766,"marketCap":229631639},{"date":"2022-02-04","current":-4.661171,"twenty":-11.667505,"median":-8.691697,"eighty":-4.27811,"marketCap":218515308},{"date":"2022-02-11","current":-4.261448,"twenty":-11.650776,"median":-8.685495,"eighty":-4.27811,"marketCap":199776350},{"date":"2022-02-18","current":-4.417272,"twenty":-11.639313,"median":-8.663585,"eighty":-4.288338,"marketCap":207081367},{"date":"2022-02-25","current":-4.058199,"twenty":-11.639313,"median":-8.653388,"eighty":-4.2766,"marketCap":190248066},{"date":"2022-03-04","current":-3.394254,"twenty":-11.636313,"median":-8.645256,"eighty":-4.260643,"marketCap":159122339},{"date":"2022-03-11","current":-3.22488,"twenty":-11.631856,"median":-8.634239,"eighty":-4.233928,"marketCap":151182102},{"date":"2022-03-18","current":-4.171078,"twenty":-11.61032,"median":-8.602069,"eighty":-4.183471,"marketCap":184199717},{"date":"2022-03-25","current":-3.745,"twenty":-11.575663,"median":-8.581754,"eighty":-4.171078,"marketCap":165383617},{"date":"2022-04-01","current":-3.879551,"twenty":-11.564852,"median":-8.544675,"eighty":-4.153568,"marketCap":171325543},{"date":"2022-04-08","current":-3.965514,"twenty":-11.560296,"median":-8.533907,"eighty":-4.153049,"marketCap":175121774},{"date":"2022-04-14","current":-3.393673,"twenty":-11.537931,"median":-8.530977,"eighty":-4.142609,"marketCap":149868587},{"date":"2022-04-22","current":-3.303972,"twenty":-11.53234,"median":-8.480576,"eighty":-4.124764,"marketCap":145907302},{"date":"2022-04-29","current":-3.171879,"twenty":-11.492652,"median":-8.473353,"eighty":-4.117911,"marketCap":140073888},{"date":"2022-05-06","current":-3.147849,"twenty":-11.44694,"median":-8.465356,"eighty":-4.111707,"marketCap":139012722},{"date":"2022-05-13","current":-2.781319,"twenty":-11.436722,"median":-8.445863,"eighty":-4.10283,"marketCap":127693620},{"date":"2022-05-20","current":-2.54248,"twenty":-11.43171,"median":-8.43297,"eighty":-4.086285,"marketCap":116728240},{"date":"2022-05-27","current":-2.973931,"twenty":-11.36492,"median":-8.426844,"eighty":-4.057183,"marketCap":136536668},{"date":"2022-06-03","current":-3.012453,"twenty":-11.341544,"median":-8.410838,"eighty":-4.0424,"marketCap":138305278},{"date":"2022-06-10","current":-2.588707,"twenty":-11.317025,"median":-8.364962,"eighty":-4.016062,"marketCap":118850571},{"date":"2022-06-17","current":-2.242005,"twenty":-11.299304,"median":-8.351361,"eighty":-4.003693,"marketCap":102933084},{"date":"2022-06-24","current":-2.311345,"twenty":-11.266497,"median":-8.327927,"eighty":-3.985546,"marketCap":106116582},{"date":"2022-07-01","current":-1.887599,"twenty":-11.220787,"median":-8.323201,"eighty":-3.963835,"marketCap":86661875},{"date":"2022-07-08","current":-2.203483,"twenty":-11.218663,"median":-8.30792,"eighty":-3.9383,"marketCap":101164474},{"date":"2022-07-15","current":-2.026279,"twenty":-11.204638,"median":-8.301526,"eighty":-3.91415,"marketCap":93028870},{"date":"2022-07-22","current":-1.995461,"twenty":-11.15585,"median":-8.291426,"eighty":-3.901459,"marketCap":91613982},{"date":"2022-07-29","current":-2.09562,"twenty":-11.129142,"median":-8.276903,"eighty":-3.887563,"marketCap":96212367},{"date":"2022-08-05","current":-2.202296,"twenty":-11.073609,"median":-8.263308,"eighty":-3.873226,"marketCap":107560498},{"date":"2022-08-12","current":-2.44136,"twenty":-11.064271,"median":-8.253224,"eighty":-3.86728,"marketCap":119236473},{"date":"2022-08-19","current":-2.20954,"twenty":-11.061934,"median":-8.2308,"eighty":-3.852685,"marketCap":107914316},{"date":"2022-08-26","current":-2.035674,"twenty":-11.051421,"median":-8.199666,"eighty":-3.807318,"marketCap":99422697},{"date":"2022-09-02","current":-2.238517,"twenty":-11.045086,"median":-8.178782,"eighty":-3.792956,"marketCap":109329585},{"date":"2022-09-09","current":-2.376161,"twenty":-11.038369,"median":-8.171607,"eighty":-3.779717,"marketCap":116052117},{"date":"2022-09-16","current":-2.195051,"twenty":-11.017587,"median":-8.133909,"eighty":-3.771862,"marketCap":107206681},{"date":"2022-09-23","current":-1.919764,"twenty":-10.976786,"median":-8.062199,"eighty":-3.765124,"marketCap":93761618},{"date":"2022-09-30","current":-1.6155,"twenty":-10.955106,"median":-8.011803,"eighty":-3.745,"marketCap":78901286},{"date":"2022-10-07","current":-2.20954,"twenty":-10.913109,"median":-8.001224,"eighty":-3.718089,"marketCap":107914316},{"date":"2022-10-14","current":-1.861809,"twenty":-10.85419,"median":-7.967138,"eighty":-3.67025,"marketCap":90931079},{"date":"2022-10-21","current":-1.803854,"twenty":-10.81895,"median":-7.936513,"eighty":-3.648376,"marketCap":88100540},{"date":"2022-10-28","current":-1.927009,"twenty":-10.789597,"median":-7.919163,"eighty":-3.633782,"marketCap":94115436},{"date":"2022-11-04","current":-2.39065,"twenty":-10.77924,"median":-7.897018,"eighty":-3.60946,"marketCap":116759751},{"date":"2022-11-11","current":-2.274739,"twenty":-10.711232,"median":-7.850468,"eighty":-3.575408,"marketCap":111098673},{"date":"2022-11-18","current":-2.434536,"twenty":-10.696985,"median":-7.8209,"eighty":-3.541357,"marketCap":113941574},{"date":"2022-11-25","current":-2.661356,"twenty":-10.648033,"median":-7.805192,"eighty":-3.526006,"marketCap":124557248},{"date":"2022-12-02","current":-2.986465,"twenty":-10.628441,"median":-7.77052,"eighty":-3.505545,"marketCap":139773048},{"date":"2022-12-09","current":-2.374051,"twenty":-10.626216,"median":-7.750551,"eighty":-3.476372,"marketCap":111110727},{"date":"2022-12-16","current":-2.041381,"twenty":-10.620433,"median":-7.738874,"eighty":-3.459203,"marketCap":95541071},{"date":"2022-12-23","current":-2.079184,"twenty":-10.606049,"median":-7.723451,"eighty":-3.415167,"marketCap":97310350},{"date":"2022-12-30","current":-2.621059,"twenty":-10.587344,"median":-7.692176,"eighty":-3.394711,"marketCap":122671261},{"date":"2023-01-06","current":-2.611862,"twenty":-10.539819,"median":-7.662477,"eighty":-3.378882,"marketCap":122240836},{"date":"2023-01-13","current":-3.200451,"twenty":-10.513866,"median":-7.615052,"eighty":-3.356884,"marketCap":149788067},{"date":"2023-01-20","current":-3.209648,"twenty":-10.482638,"median":-7.508524,"eighty":-3.315886,"marketCap":150218492},{"date":"2023-01-27","current":-3.163664,"twenty":-10.436007,"median":-7.41703,"eighty":-3.296478,"marketCap":148066365},{"date":"2023-02-03","current":-3.292418,"twenty":-10.394317,"median":-7.381381,"eighty":-3.270823,"marketCap":154092321},{"date":"2023-02-10","current":-3.117681,"twenty":-10.315214,"median":-7.347003,"eighty":-3.237485,"marketCap":145914237},{"date":"2023-02-17","current":-2.92455,"twenty":-10.262034,"median":-7.28916,"eighty":-3.209648,"marketCap":136875302},{"date":"2023-02-24","current":-2.584272,"twenty":-10.199437,"median":-7.181455,"eighty":-3.197234,"marketCap":120949559},{"date":"2023-03-03","current":-2.694633,"twenty":-10.165591,"median":-7.105904,"eighty":-3.168593,"marketCap":126114665},{"date":"2023-03-10","current":-2.216404,"twenty":-10.132757,"median":-6.933834,"eighty":-3.136074,"marketCap":103732540},{"date":"2023-03-17","current":-2.795796,"twenty":-10.079114,"median":-6.713983,"eighty":-3.101127,"marketCap":130849345},{"date":"2023-03-24","current":-2.703608,"twenty":-10.043407,"median":-6.611719,"eighty":-3.04661,"marketCap":143319313},{"date":"2023-03-31","current":-2.907193,"twenty":-10.026871,"median":-6.363768,"eighty":-3.02478,"marketCap":154111430},{"date":"2023-04-06","current":-2.662891,"twenty":-10.000722,"median":-6.247005,"eighty":-2.993585,"marketCap":141160890},{"date":"2023-04-14","current":-2.85019,"twenty":-9.944483,"median":-6.151661,"eighty":-2.976884,"marketCap":151089638},{"date":"2023-04-21","current":-2.87462,"twenty":-9.888931,"median":-6.11852,"eighty":-2.949352,"marketCap":152384692},{"date":"2023-04-28","current":-3.501661,"twenty":-9.858052,"median":-6.104023,"eighty":-2.949352,"marketCap":185624412},{"date":"2023-05-05","current":-3.754949,"twenty":-9.800073,"median":-6.017605,"eighty":-2.949352,"marketCap":199051271},{"date":"2023-05-12","current":-3.90452,"twenty":-9.740149,"median":-6.004306,"eighty":-2.949352,"marketCap":202505523},{"date":"2023-05-19","current":-3.321756,"twenty":-9.683779,"median":-5.853093,"eighty":-2.949352,"marketCap":172280818},{"date":"2023-05-26","current":-3.288455,"twenty":-9.661242,"median":-5.705088,"eighty":-2.949352,"marketCap":170553692},{"date":"2023-06-02","current":-3.380032,"twenty":-9.656345,"median":-5.552155,"eighty":-2.949352,"marketCap":175303289},{"date":"2023-06-09","current":-3.138601,"twenty":-9.60659,"median":-5.41252,"eighty":-2.949352,"marketCap":162781625},{"date":"2023-06-16","current":-3.221853,"twenty":-9.577979,"median":-5.259586,"eighty":-2.949352,"marketCap":167099440},{"date":"2023-06-23","current":-3.246829,"twenty":-9.57887,"median":-5.204239,"eighty":-2.947958,"marketCap":168394785},{"date":"2023-06-30","current":-3.063675,"twenty":-9.579761,"median":-5.123645,"eighty":-2.941915,"marketCap":158895592},{"date":"2023-07-07","current":-3.221853,"twenty":-9.579761,"median":-4.973667,"eighty":-2.93638,"marketCap":167099440},{"date":"2023-07-14","current":-3.71304,"twenty":-9.579761,"median":-4.898294,"eighty":-2.93638,"marketCap":192574549},{"date":"2023-07-21","current":-3.563187,"twenty":-9.579761,"median":-4.81022,"eighty":-2.93638,"marketCap":184802482},{"date":"2023-07-28","current":-3.072,"twenty":-9.579761,"median":-4.78192,"eighty":-2.93638,"marketCap":159327373},{"date":"2023-08-04","current":-3.105301,"twenty":-9.579761,"median":-4.760644,"eighty":-2.93638,"marketCap":161054499},{"date":"2023-08-11","current":-2.723172,"twenty":-9.579761,"median":-4.712771,"eighty":-2.930471,"marketCap":141172980},{"date":"2023-08-18","current":-2.532376,"twenty":-9.579761,"median":-4.661171,"eighty":-2.915966,"marketCap":131281880},{"date":"2023-08-25","current":-2.506359,"twenty":-9.579761,"median":-4.601069,"eighty":-2.899175,"marketCap":129933093},{"date":"2023-09-01","current":-2.350253,"twenty":-9.579761,"median":-4.542558,"eighty":-2.880782,"marketCap":121840375},{"date":"2023-09-08","current":-2.272201,"twenty":-9.579761,"median":-4.500005,"eighty":-2.86022,"marketCap":117794015},{"date":"2023-09-15","current":-2.306891,"twenty":-9.579761,"median":-4.482539,"eighty":-2.847888,"marketCap":119592397},{"date":"2023-09-22","current":-2.055387,"twenty":-9.579761,"median":-4.454915,"eighty":-2.83754,"marketCap":106554128},{"date":"2023-09-29","current":-2.012025,"twenty":-9.579761,"median":-4.419758,"eighty":-2.822028,"marketCap":104306151},{"date":"2023-10-06","current":-1.933972,"twenty":-9.579761,"median":-4.399669,"eighty":-2.799939,"marketCap":100259792},{"date":"2023-10-13","current":-1.751849,"twenty":-9.579761,"median":-4.373186,"eighty":-2.78302,"marketCap":90818286},{"date":"2023-10-20","current":-1.621761,"twenty":-9.579761,"median":-4.345749,"eighty":-2.768206,"marketCap":84074354},{"date":"2023-10-27","current":-1.613089,"twenty":-9.580902,"median":-4.340063,"eighty":-2.758687,"marketCap":83624759},{"date":"2023-11-03","current":-1.9253,"twenty":-9.580902,"median":-4.325012,"eighty":-2.750501,"marketCap":99810196},{"date":"2023-11-10","current":-1.804361,"twenty":-9.580902,"median":-4.280376,"eighty":-2.740616,"marketCap":93630808},{"date":"2023-11-17","current":-2.069581,"twenty":-9.580902,"median":-4.280376,"eighty":-2.70498,"marketCap":107393408},{"date":"2023-11-24","current":-2.121755,"twenty":-9.580902,"median":-4.280376,"eighty":-2.697681,"marketCap":110100805},{"date":"2023-12-01","current":-2.173929,"twenty":-9.580902,"median":-4.280376,"eighty":-2.694423,"marketCap":112808202},{"date":"2023-12-08","current":-2.652194,"twenty":-9.580777,"median":-4.2766,"eighty":-2.69327,"marketCap":137626007},{"date":"2023-12-15","current":-2.443497,"twenty":-9.580777,"median":-4.2766,"eighty":-2.685543,"marketCap":126796419},{"date":"2023-12-22","current":-2.452192,"twenty":-9.580777,"median":-4.2766,"eighty":-2.66518,"marketCap":127247652},{"date":"2023-12-29","current":-2.469584,"twenty":-9.580902,"median":-4.280376,"eighty":-2.675452,"marketCap":128150118},{"date":"2024-01-05","current":-2.330452,"twenty":-9.581026,"median":-4.284152,"eighty":-2.664035,"marketCap":120930393},{"date":"2024-01-12","current":-2.617411,"twenty":-9.581026,"median":-4.284152,"eighty":-2.661799,"marketCap":135821075},{"date":"2024-01-19","current":-2.365235,"twenty":-9.581151,"median":-4.291153,"eighty":-2.640883,"marketCap":122735324},{"date":"2024-01-26","current":-2.347844,"twenty":-9.581026,"median":-4.284152,"eighty":-2.618257,"marketCap":121832858},{"date":"2024-02-02","current":-2.217408,"twenty":-9.581026,"median":-4.284152,"eighty":-2.605956,"marketCap":115064366},{"date":"2024-02-09","current":-2.043494,"twenty":-9.581026,"median":-4.284152,"eighty":-2.595858,"marketCap":106039710},{"date":"2024-02-16","current":-2.043494,"twenty":-9.581026,"median":-4.284152,"eighty":-2.569557,"marketCap":106039710},{"date":"2024-02-23","current":-1.773926,"twenty":-9.581026,"median":-4.284152,"eighty":-2.548261,"marketCap":92051493},{"date":"2024-03-01","current":-1.804361,"twenty":-9.580902,"median":-4.280376,"eighty":-2.538806,"marketCap":93630808},{"date":"2024-03-08","current":-1.713056,"twenty":-9.580902,"median":-4.280376,"eighty":-2.508963,"marketCap":88892863},{"date":"2024-03-15","current":-1.765231,"twenty":-9.580902,"median":-4.280376,"eighty":-2.470835,"marketCap":91600260},{"date":"2024-03-22","current":-1.686969,"twenty":-9.580902,"median":-4.259842,"eighty":-2.45942,"marketCap":87539165},{"date":"2024-03-28","current":-1.600012,"twenty":-9.580902,"median":-4.259842,"eighty":-2.452192,"marketCap":83026837},{"date":"2024-04-05","current":-1.706682,"twenty":-9.581026,"median":-4.233928,"eighty":-2.440033,"marketCap":86585102},{"date":"2024-04-12","current":-1.687506,"twenty":-9.581026,"median":-4.171078,"eighty":-2.427319,"marketCap":85612236},{"date":"2024-04-19","current":-1.51492,"twenty":-9.581026,"median":-4.153049,"eighty":-2.410047,"marketCap":76856439},{"date":"2024-04-26","current":-1.351922,"twenty":-9.580902,"median":-4.131245,"eighty":-2.394996,"marketCap":68587075},{"date":"2024-05-03","current":-1.802563,"twenty":-9.580902,"median":-4.118411,"eighty":-2.381241,"marketCap":91449434},{"date":"2024-05-10","current":-1.86412,"twenty":-9.580902,"median":-4.109514,"eighty":-2.367946,"marketCap":93151950},{"date":"2024-05-17","current":-1.69377,"twenty":-9.580902,"median":-4.103573,"eighty":-2.358384,"marketCap":84639369},{"date":"2024-05-24","current":-1.69377,"twenty":-9.580902,"median":-4.091076,"eighty":-2.34758,"marketCap":84639369},{"date":"2024-05-31","current":-1.547755,"twenty":-9.580902,"median":-4.073526,"eighty":-2.332695,"marketCap":77342872},{"date":"2024-06-07","current":-1.576958,"twenty":-9.580902,"median":-4.073526,"eighty":-2.323244,"marketCap":78802171},{"date":"2024-06-14","current":-1.499084,"twenty":-9.581026,"median":-4.0424,"eighty":-2.304941,"marketCap":74910706},{"date":"2024-06-21","current":-1.26546,"twenty":-9.581151,"median":-4.047759,"eighty":-2.290516,"marketCap":63236310},{"date":"2024-06-28","current":-1.362803,"twenty":-9.581276,"median":-4.058199,"eighty":-2.284534,"marketCap":68100642},{"date":"2024-07-05","current":-0.953962,"twenty":-9.581276,"median":-4.028007,"eighty":-2.272574,"marketCap":47670449},{"date":"2024-07-12","current":-0.923105,"twenty":-9.581276,"median":-4.028007,"eighty":-2.255651,"marketCap":46128456},{"date":"2024-07-15","current":-0.91522,"twenty":-9.581276,"median":-4.028007,"eighty":-2.250108,"marketCap":45734445},{"date":"2024-08-02","current":-0.754506,"twenty":-9.60639,"median":-4.103573,"eighty":-2.238517,"marketCap":37703434},{"date":"2024-08-09","current":-0.642562,"twenty":-9.60639,"median":-4.098321,"eighty":-2.220165,"marketCap":32109452},{"date":"2024-08-16","current":-0.615228,"twenty":-9.60639,"median":-4.091076,"eighty":-2.216404,"marketCap":28889265},{"date":"2024-08-23","current":-0.844372,"twenty":-9.60639,"median":-4.043103,"eighty":-2.207716,"marketCap":39649166},{"date":"2024-08-30","current":-0.746892,"twenty":-9.60639,"median":-4.033058,"eighty":-2.202296,"marketCap":35071830},{"date":"2024-09-06","current":-0.652625,"twenty":-9.60639,"median":-3.974265,"eighty":-2.195051,"marketCap":30645289},{"date":"2024-09-13","current":-0.600829,"twenty":-9.60639,"median":-3.90452,"eighty":-2.180562,"marketCap":28213123},{"date":"2024-09-20","current":-0.58529,"twenty":-9.60639,"median":-3.874822,"eighty":-2.13967,"marketCap":27483473},{"date":"2024-09-27","current":-0.470408,"twenty":-9.60639,"median":-3.79161,"eighty":-2.129852,"marketCap":22088929},{"date":"2024-10-04","current":-0.848619,"twenty":-9.60639,"median":-3.766997,"eighty":-2.121755,"marketCap":39848604},{"date":"2024-10-11","current":-1.377763,"twenty":-9.60639,"median":-3.745,"eighty":-2.103324,"marketCap":64695610},{"date":"2024-10-18","current":-1.423229,"twenty":-9.60639,"median":-3.745,"eighty":-2.087915,"marketCap":66830565},{"date":"2024-10-25","current":-2.000214,"twenty":-9.60639,"median":-3.704715,"eighty":-2.080211,"marketCap":93924038},{"date":"2024-10-31","current":-2.24383,"twenty":-9.60639,"median":-3.666669,"eighty":-2.079184,"marketCap":105363504},{"date":"2024-11-08","current":-2.282295,"twenty":-9.60649,"median":-3.563536,"eighty":-2.076538,"marketCap":107169736},{"date":"2024-11-15","current":-1.923282,"twenty":-9.60649,"median":-3.505799,"eighty":-2.069581,"marketCap":90311575},{"date":"2024-11-22","current":-1.46263,"twenty":-9.60649,"median":-3.460948,"eighty":-2.063899,"marketCap":65250836},{"date":"2024-11-29","current":-1.732435,"twenty":-9.60649,"median":-3.421658,"eighty":-2.054747,"marketCap":77287398},{"date":"2024-12-06","current":-1.49103,"twenty":-9.60649,"median":-3.394254,"eighty":-2.046071,"marketCap":66517843},{"date":"2024-12-13","current":-1.48393,"twenty":-9.60649,"median":-3.371707,"eighty":-2.041688,"marketCap":66201091},{"date":"2024-12-20","current":-1.448429,"twenty":-9.60649,"median":-3.330081,"eighty":-2.032742,"marketCap":64617333},{"date":"2024-12-27","current":-1.533631,"twenty":-9.581276,"median":-3.305106,"eighty":-2.026228,"marketCap":68418353},{"date":"2025-01-03","current":-1.547831,"twenty":-9.580777,"median":-3.292418,"eighty":-2.012834,"marketCap":69051856},{"date":"2025-01-10","current":-2.059042,"twenty":-9.580902,"median":-3.27791,"eighty":-2.011563,"marketCap":91857974},{"date":"2025-01-17","current":-1.817637,"twenty":-9.577979,"median":-3.242666,"eighty":-2.000134,"marketCap":81088418},{"date":"2025-01-24","current":-1.97384,"twenty":-9.577979,"median":-3.227051,"eighty":-1.991977,"marketCap":88056954},{"date":"2025-01-31","current":-1.931239,"twenty":-9.576762,"median":-3.212728,"eighty":-1.977603,"marketCap":86156444},{"date":"2025-02-07","current":-1.917039,"twenty":-9.566807,"median":-3.202184,"eighty":-1.973893,"marketCap":85522941},{"date":"2025-02-14","current":-2.016441,"twenty":-9.51739,"median":-3.182058,"eighty":-1.953154,"marketCap":89957464},{"date":"2025-02-21","current":-1.94544,"twenty":-9.506622,"median":-3.167771,"eighty":-1.947532,"marketCap":86789947},{"date":"2025-02-28","current":-1.760836,"twenty":-9.490001,"median":-3.147388,"eighty":-1.933972,"marketCap":78554405},{"date":"2025-03-07","current":-1.519431,"twenty":-9.424151,"median":-3.138601,"eighty":-1.927009,"marketCap":67784849},{"date":"2025-03-14","current":-1.383108,"twenty":-9.406351,"median":-3.117681,"eighty":-1.921171,"marketCap":61703218},{"date":"2025-03-21","current":-1.363228,"twenty":-9.406351,"median":-3.090091,"eighty":-1.904727,"marketCap":60816313},{"date":"2025-03-28","current":-1.420029,"twenty":-9.372589,"median":-3.072,"eighty":-1.897796,"marketCap":63350327},{"date":"2025-04-04","current":-1.184645,"twenty":-9.326167,"median":-3.037488,"eighty":-1.884202,"marketCap":48184258},{"date":"2025-04-11","current":-1.092481,"twenty":-9.311641,"median":-3.002722,"eighty":-1.861181,"marketCap":44435569},{"date":"2025-04-17","current":-1.183977,"twenty":-9.289858,"median":-2.987111,"eighty":-1.85592,"marketCap":48157079},{"date":"2025-04-25","current":-1.586879,"twenty":-9.265249,"median":-2.94517,"eighty":-1.834844,"marketCap":64544708},{"date":"2025-05-02","current":-1.392733,"twenty":-9.232607,"median":-2.930471,"eighty":-1.82327,"marketCap":56648040},{"date":"2025-05-09","current":-1.422744,"twenty":-9.188477,"median":-2.912295,"eighty":-1.819132,"marketCap":57868708},{"date":"2025-05-16","current":-1.343836,"twenty":-9.139017,"median":-2.882763,"eighty":-1.808709,"marketCap":54538243},{"date":"2025-05-23","current":-1.31283,"twenty":-9.034572,"median":-2.85019,"eighty":-1.803437,"marketCap":53279900},{"date":"2025-05-30","current":-1.195676,"twenty":-9.022145,"median":-2.827546,"eighty":-1.786539,"marketCap":48525323},{"date":"2025-06-06","current":-1.169869,"twenty":-8.947706,"median":-2.817616,"eighty":-1.771036,"marketCap":47477960},{"date":"2025-06-13","current":-1.180266,"twenty":-8.88187,"median":-2.781319,"eighty":-1.751849,"marketCap":47899919},{"date":"2025-06-20","current":-1.217028,"twenty":-8.848285,"median":-2.758607,"eighty":-1.734955,"marketCap":49391846},{"date":"2025-06-27","current":-1.465632,"twenty":-8.802246,"median":-2.750501,"eighty":-1.73064,"marketCap":59481196},{"date":"2025-07-03","current":-1.290736,"twenty":-8.784451,"median":-2.71339,"eighty":-1.718938,"marketCap":52383237},{"date":"2025-07-11","current":-1.477885,"twenty":-8.737645,"median":-2.695049,"eighty":-1.704564,"marketCap":59978505},{"date":"2025-07-18","current":-1.559578,"twenty":-8.700822,"median":-2.679045,"eighty":-1.69377,"marketCap":63293900},{"date":"2025-07-25","current":-1.680259,"twenty":-8.657053,"median":-2.662464,"eighty":-1.686969,"marketCap":68191642},{"date":"2025-08-01","current":-1.393594,"twenty":-8.599199,"median":-2.643028,"eighty":-1.672364,"marketCap":56557620},{"date":"2025-08-08","current":-1.503878,"twenty":-8.535694,"median":-2.618468,"eighty":-1.661434,"marketCap":61033403},{"date":"2025-08-15","current":-1.560824,"twenty":-8.473606,"median":-2.606415,"eighty":-1.652186,"marketCap":60708264},{"date":"2025-08-22","current":-1.603105,"twenty":-8.445176,"median":-2.590896,"eighty":-1.623799,"marketCap":62352766},{"date":"2025-08-29","current":-1.583545,"twenty":-8.417961,"median":-2.565736,"eighty":-1.618833,"marketCap":61591992},{"date":"2025-09-05","current":-1.550946,"twenty":-8.351361,"median":-2.54248,"eighty":-1.61654,"marketCap":60324034},{"date":"2025-09-12","current":-1.512814,"twenty":-8.323201,"median":-2.535443,"eighty":-1.606161,"marketCap":58840908},{"date":"2025-09-19","current":-1.442478,"twenty":-8.304269,"median":-2.505363,"eighty":-1.600012,"marketCap":56105194},{"date":"2025-09-26","current":-1.363449,"twenty":-8.269904,"median":-2.470626,"eighty":-1.58736,"marketCap":53031358},{"date":"2025-10-03","current":-1.419757,"twenty":-8.2035,"median":-2.459053,"eighty":-1.576958,"marketCap":55221466},{"date":"2025-10-10","current":-1.830116,"twenty":-8.141673,"median":-2.450925,"eighty":-1.566752,"marketCap":71182360},{"date":"2025-10-17","current":-1.561022,"twenty":-8.001224,"median":-2.438064,"eighty":-1.562198,"marketCap":60715948},{"date":"2025-10-24","current":-1.54166,"twenty":-7.936093,"median":-2.423273,"eighty":-1.561224,"marketCap":59962858},{"date":"2025-10-31","current":-1.381823,"twenty":-7.859795,"median":-2.404716,"eighty":-1.553115,"marketCap":53746025},{"date":"2025-11-07","current":-1.414423,"twenty":-7.817758,"median":-2.394171,"eighty":-1.549607,"marketCap":55013982},{"date":"2025-11-14","current":-1.22416,"twenty":-7.755971,"median":-2.381149,"eighty":-1.547831,"marketCap":47613722},{"date":"2025-11-21","current":-1.129989,"twenty":-7.723451,"median":-2.367704,"eighty":-1.541502,"marketCap":42581367},{"date":"2025-11-28","current":-1.31637,"twenty":-7.670548,"median":-2.360299,"eighty":-1.535716,"marketCap":49604773},{"date":"2025-12-05","current":-1.15548,"twenty":-7.639269,"median":-2.348856,"eighty":-1.523002,"marketCap":43541968},{"date":"2025-12-12","current":-1.03053,"twenty":-7.54248,"median":-2.332695,"eighty":-1.516965,"marketCap":38833451},{"date":"2025-12-19","current":-0.714601,"twenty":-7.420819,"median":-2.322996,"eighty":-1.50942,"marketCap":26928305},{"date":"2025-12-26","current":-0.503564,"twenty":-7.387031,"median":-2.305266,"eighty":-1.505231,"marketCap":18975794},{"date":"2026-01-02","current":-0.739432,"twenty":-7.359673,"median":-2.292448,"eighty":-1.491973,"marketCap":27864004},{"date":"2026-01-09","current":-0.951286,"twenty":-7.27935,"median":-2.281584,"eighty":-1.477041,"marketCap":35847306},{"date":"2026-01-16","current":-0.67067,"twenty":-7.133825,"median":-2.272124,"eighty":-1.463948,"marketCap":25272852},{"date":"2026-01-23","current":-0.88325,"twenty":-6.735662,"median":-2.258832,"eighty":-1.46263,"marketCap":33283526},{"date":"2026-01-30","current":-0.874776,"twenty":-6.167921,"median":-2.240261,"eighty":-1.457906,"marketCap":32964194},{"date":"2026-02-06","current":-0.765338,"twenty":-5.201812,"median":-2.230398,"eighty":-1.450731,"marketCap":28840248},{"date":"2026-02-13","current":-0.726357,"twenty":-4.75331,"median":-2.217408,"eighty":-1.448429,"marketCap":27371320},{"date":"2026-02-19","current":-0.719336,"twenty":-4.666591,"median":-2.20954,"eighty":-1.442504,"marketCap":27106731}],"updateTime":1771637643987},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CUE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612745268","title":"Cue Biopharma Reports Positive Preclinical Safety Data for CUE-401","url":"https://stock-news.laohu8.com/highlight/detail?id=2612745268","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612745268?lang=en_us&edition=fundamental","pubTime":"2026-02-17 21:01","pubTimestamp":1771333297,"startTime":"0","endTime":"0","summary":"Cue Biopharma Inc. announced new preclinical safety and tolerability data for its lead autoimmune asset, CUE-401. In two non-GLP studies involving mice and non-human primates, CUE-401 was well tolerated with no adverse events observed at escalating dose levels. The company stated that further scientific data and details regarding its planned investigational new drug  filing for CUE-401 will be shared in the coming months. Results from these preclinical studies have been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cue Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire  on February 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL4MVx4V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","SG9999014013.SGD","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014021.USD","IE00BKPKM429.USD","NDAQ","CUE","LU0314104364.USD","BK4588","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014005.SGD","BK4585","SG9999014039.USD","BK4139","BK4112"],"gpt_icon":0},{"id":"2612452697","title":"Cue Biopharma Inc - Cue-401 Well Tolerated With No Adverse Events in Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2612452697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612452697?lang=en_us&edition=fundamental","pubTime":"2026-02-17 21:00","pubTimestamp":1771333212,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nTUA6T2XD2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CUE"],"gpt_icon":0},{"id":"2610692954","title":"Press Release: Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2610692954","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610692954?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:00","pubTimestamp":1770901200,"startTime":"0","endTime":"0","summary":"BOSTON, Feb. 12, 2026  -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune and inflammatory diseases, today announced that Lucinda Warren, who has served as Cue Biopharma's chief business officer  since September 2024, has been appointed chief financial and business officer  effective February 9, 2026.Ms. Warren added, \"I am honored to serve Cue Biopharma in this capacity, and I look forward to continuing to support the Company's corporate priorities and to be a part of this dedicated team.\"","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","R","BK4099","BK4022","TM","BK4585","CUE","BK4604","BK4588","BK4139","BK4232","BK4555"],"gpt_icon":0},{"id":"2605415865","title":"Cue Biopharma’s CUE-101 Trial Hits Completion: What It Means for Cancer Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2605415865","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605415865?lang=en_us&edition=fundamental","pubTime":"2026-01-23 00:30","pubTimestamp":1769099414,"startTime":"0","endTime":"0","summary":"Cue Biopharma ($CUE) announced an update on their ongoing clinical study. Cue Biopharma’s HPV-Linked Head and Neck Cancer Study Reaches Key Milesto...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cue-biopharmas-cue-101-trial-hits-completion-what-it-means-for-cancer-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cue-biopharmas-cue-101-trial-hits-completion-what-it-means-for-cancer-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","BK4139","ISBC","CUE"],"gpt_icon":0},{"id":"2600098472","title":"Director Pasha Sarraf Reports Acquisition of Cue Biopharma Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2600098472","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600098472?lang=en_us&edition=fundamental","pubTime":"2026-01-03 05:00","pubTimestamp":1767387642,"startTime":"0","endTime":"0","summary":"Pasha Sarraf, Director of Cue Biopharma Inc., has reported the acquisition of common shares of Cue Biopharma Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cue Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260102:nNDL2ZMFXk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director Pasha Sarraf Reports Acquisition of Cue Biopharma Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CUE"],"gpt_icon":0},{"id":"2592167800","title":"BRIEF-Cue Biopharma Announces Pricing Of $10 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2592167800","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592167800?lang=en_us&edition=fundamental","pubTime":"2025-12-19 21:31","pubTimestamp":1766151069,"startTime":"0","endTime":"0","summary":"BRIEF-Cue Biopharma Announces Pricing Of $10 Million Public OfferingDec 19 (Reuters) - Cue Biopharma Inc CUE.O:CUE BIOPHARMA ANNOUNCES PRICING OF $10 MILLION PUBLIC OFFERINGCUE BIOPHARMA INC - SHARES ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nTUA8G0D6B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CUE"],"gpt_icon":0},{"id":"2592162804","title":"Cue Biopharma Inc - Shares and Warrants Sold at Combined Price of $0.28","url":"https://stock-news.laohu8.com/highlight/detail?id=2592162804","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592162804?lang=en_us&edition=fundamental","pubTime":"2025-12-19 21:00","pubTimestamp":1766149200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nTUA8G0D6B:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CUE"],"gpt_icon":0},{"id":"2592818162","title":"Press Release: Cue Biopharma Announces Proposed Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2592818162","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592818162?lang=en_us&edition=fundamental","pubTime":"2025-12-19 05:02","pubTimestamp":1766091720,"startTime":"0","endTime":"0","summary":"BOSTON, Dec. 18, 2025  -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune disease, today announced that it is commencing an underwritten public offering of shares of its common stock  and accompanying warrants to purchase shares of common stock. In addition, Cue Biopharma intends to grant the underwriters an option for a period of 30 days to purchase up to an additional 15% of the shares of its common stock and/or warrants to purchase shares of common stock offered in the public offering. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering. All of the securities are being offered by Cue Biopharma.H.C. Wainwright & Co. is acting as sole book-running manager for the proposed offering. Newb","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4232","CUE","R","BK4022"],"gpt_icon":0},{"id":"2585574321","title":"Cue Biopharma Chief Medical Officer Matteo Levisetti to Depart","url":"https://stock-news.laohu8.com/highlight/detail?id=2585574321","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585574321?lang=en_us&edition=fundamental","pubTime":"2025-11-21 05:00","pubTimestamp":1763672453,"startTime":"0","endTime":"0","summary":"Cue Biopharma Inc. announced that Chief Medical Officer Matteo Levisetti will depart from the company effective November 28, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cue Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 20, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL9PwZ8P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CUE"],"gpt_icon":0},{"id":"2584792677","title":"Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2584792677","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584792677?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:55","pubTimestamp":1763571340,"startTime":"0","endTime":"0","summary":"Nov 6 (Reuters) - Cue Biopharma Inc ::*CUE BIOPHARMA AND IMMUNOSCAPE ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP BREAKTHROUGH CELL THERAPY APPROACH FOR SOLID TUMORS  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 06-NOV-202513:00:04.11 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD91jp3Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CUE"],"gpt_icon":0},{"id":"2583465513","title":"BRIEF-Immunoscape Signs Deal With Cue Biopharma To Develop Solid Tumor Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2583465513","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583465513?lang=en_us&edition=fundamental","pubTime":"2025-11-14 02:37","pubTimestamp":1763059078,"startTime":"0","endTime":"0","summary":"BRIEF-Immunoscape Signs Deal With Cue Biopharma To Develop Solid Tumor Cancer TreatmentNov 13 (Reuters) - ImmunoScape:IMMUNOSCAPE: ENTERED IN-LICENSING DEAL WITH CUE BIOPHARMA FOR DEVELOPMENT OF NEW C","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WP1WJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","LU0058720904.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","LU2112291526.USD","BK4534","AMGN","IE00BJJMRZ35.SGD","LU1057294990.SGD","SG9999001440.SGD","BK4566","LU0320765992.SGD","BK4139","LU1571399168.USD","IE0002141913.USD","BK4533","LU1061106388.HKD","IE00BFTCPJ56.SGD","LU0109394709.USD","IE00B2B36J28.USD","BK4599","CUE","LU2468319806.SGD","BK4585","LU2242652126.USD","LU1023059063.AUD","LU2089984988.USD","IE0009355771.USD","BK4588","BK4581","LU1983299246.USD","IE00BJT1NW94.SGD","LU0122379950.USD","LU2242646821.SGD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2583851384","title":"Immunoscape: Entered in-Licensing Deal With Cue Biopharma for Development of New Class of Therapies to Attack Solid Tumor Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2583851384","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583851384?lang=en_us&edition=fundamental","pubTime":"2025-11-14 02:15","pubTimestamp":1763057723,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WP1WJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","IE00B2B36J28.USD","BK4599","LU2242646821.SGD","BK4139","LU0289739699.SGD","LU0889565916.HKD","BK4534","BK4533","LU1023059063.AUD","LU1983299246.USD","BK4585","LU0122379950.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU0320765992.SGD","IE00B4R5TH58.HKD","LU2089984988.USD","SG9999001440.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","CUE","LU2112291526.USD","IE0002141913.USD","BK4581","BK4566","LU2242652126.USD","LU0868494617.USD","LU1061106388.HKD","AMGN","LU0058720904.USD","LU2468319806.SGD","LU1571399168.USD"],"gpt_icon":0},{"id":"2583138535","title":"Cue Biopharma Licenses Immuno-STAT® Oncology Technology to ImmunoScape","url":"https://stock-news.laohu8.com/highlight/detail?id=2583138535","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583138535?lang=en_us&edition=fundamental","pubTime":"2025-11-14 02:11","pubTimestamp":1763057486,"startTime":"0","endTime":"0","summary":"Cue Biopharma Inc. has announced an exclusive in-licensing agreement with Singapore-based ImmunoScape Pte. Ltd. Under the terms of the deal, ImmunoScape will gain exclusive access to Cue Biopharma's clinical-stage Immuno-STAT molecules for development in oncology. The collaboration aims to advance next-generation TCR-based cancer immunotherapies, particularly for solid tumor cancers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cue Biopharma Inc. published the original content used to generate this news brief via Business Wire  on November 13, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDLSMryR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CUE"],"gpt_icon":0},{"id":"2583853975","title":"Cue Biopharma Q3 collaboration revenue falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2583853975","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583853975?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:35","pubTimestamp":1762983324,"startTime":"0","endTime":"0","summary":"Cue Biopharma Q3 collaborationrevenue fallsOverviewCue Biopharma Q3 collaboration revenue declinesCompany announces $15 mln collaboration with ImmunoScape for cell therapy developmentOperating expense","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nL1N3WO14I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CUE"],"gpt_icon":0},{"id":"2583090583","title":"Cue Biopharma Q3 EPS $(0.07) Beats $(0.09) Estimate, Sales $2.149M Miss $2.290M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583090583","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583090583?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:32","pubTimestamp":1762983163,"startTime":"0","endTime":"0","summary":"Cue Biopharma Q3 EPS $(0.07) Beats $(0.09) Estimate, Sales $2.149M Miss $2.290M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48820087/cue-biopharma-q3-eps-0-07-beats-0-09-estimate-sales-2-149m-miss-2-290m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cue Biopharma Q3 EPS $(0.07) Beats $(0.09) Estimate, Sales $2.149M Miss $2.290M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUE","BK4139"],"gpt_icon":0},{"id":"2583622588","title":"Cue Biopharma Names Usman Azam President and CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2583622588","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583622588?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:07","pubTimestamp":1762981629,"startTime":"0","endTime":"0","summary":"Cue Biopharma Inc. has announced a strategic transition in leadership, appointing Usman Azam, M.D., as President and Chief Executive Officer, effective September 29. This change is intended to support the company's next stage of growth, particularly in advancing its lead autoimmune asset, CUE-401.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cue Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire  on November 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL14gz1t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4112","LU0314104364.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4588","BK4139","CUE","IE00BKPKM429.USD","BK4585","LU2210150020.SGD","LU2095319765.USD","NDAQ"],"gpt_icon":0},{"id":"2583158883","title":"Cue Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2583158883","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583158883?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:05","pubTimestamp":1762981505,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nTUA58CG36:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CUE"],"gpt_icon":0},{"id":"2581099851","title":"BRIEF-Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2581099851","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581099851?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:51","pubTimestamp":1762437090,"startTime":"0","endTime":"0","summary":"BRIEF-Cue Biopharmaand ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid TumorsNov 6 (Reuters) - Cue Biopharma Inc CUE.O:CUE BIOPHARMA AND IMMUNOSCAP","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nTUA7H0SQP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CUE"],"gpt_icon":0},{"id":"2572524260","title":"Cue Biopharma Inc. Files Initial Statement of Beneficial Ownership for CEO and Director Usman Azam","url":"https://stock-news.laohu8.com/highlight/detail?id=2572524260","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572524260?lang=en_us&edition=fundamental","pubTime":"2025-10-03 08:13","pubTimestamp":1759450439,"startTime":"0","endTime":"0","summary":"Cue Biopharma Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing names Usman Azam as the beneficial owner, who currently serves as Chief Executive Officer and Director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cue Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 02, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nNDL1MYJqY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUE","BK4139"],"gpt_icon":0},{"id":"2571576339","title":"BRIEF-Cue Biopharma Appoints New CEO, Shifts Focus to Autoimmune Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2571576339","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571576339?lang=en_us&edition=fundamental","pubTime":"2025-09-29 21:13","pubTimestamp":1759151616,"startTime":"0","endTime":"0","summary":"BRIEF-Cue Biopharma Appoints New CEO, Shifts Focus to Autoimmune Therapies Sept 29 (Reuters) - Cue Biopharma Inc CUE.O:CUE BIOPHARMA ANNOUNCES STRATEGIC TRANSITION IN LEADERSHIP TO FURTHER ENABLE NEXT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nTUA674NDP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CUE"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}]}}